632 related articles for article (PubMed ID: 15983219)
1. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients.
Maxhimer JB; Somenek M; Rao G; Pesce CE; Baldwin D; Gattuso P; Schwartz MM; Lewis EJ; Prinz RA; Xu X
Diabetes; 2005 Jul; 54(7):2172-8. PubMed ID: 15983219
[TBL] [Abstract][Full Text] [Related]
2. Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation.
Rao G; Liu D; Xing M; Tauler J; Prinz RA; Xu X
Neoplasia; 2010 Nov; 12(11):946-56. PubMed ID: 21076620
[TBL] [Abstract][Full Text] [Related]
3. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
[TBL] [Abstract][Full Text] [Related]
4. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
6. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
8. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
9. Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium.
Xu X; Ding J; Rao G; Shen J; Prinz RA; Rana N; Dmowski WP
Hum Reprod; 2007 Apr; 22(4):927-37. PubMed ID: 17261577
[TBL] [Abstract][Full Text] [Related]
10. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
Kasinath BS; Grellier P; Choudhury GG; Abboud SL
J Cell Physiol; 1996 Apr; 167(1):131-6. PubMed ID: 8698830
[TBL] [Abstract][Full Text] [Related]
11. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.
Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A
Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.
Rao G; Ding HG; Huang W; Le D; Maxhimer JB; Oosterhof A; van Kuppevelt T; Lum H; Lewis EJ; Reddy V; Prinz RA; Xu X
Diabetologia; 2011 Jun; 54(6):1527-38. PubMed ID: 21424539
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation.
Xu X; Rao G; Quiros RM; Kim AW; Miao HQ; Brunn GJ; Platt JL; Gattuso P; Prinz RA
J Biol Chem; 2007 Jan; 282(4):2363-73. PubMed ID: 17121850
[TBL] [Abstract][Full Text] [Related]
14. Heparanase in glomerular diseases.
van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
[TBL] [Abstract][Full Text] [Related]
16. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
[TBL] [Abstract][Full Text] [Related]
17. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
18. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
[TBL] [Abstract][Full Text] [Related]
19. [Gene expression of heparanase in peripheral blood leukocytes from rats with nephrotic syndrome and its relationship to proteinuria].
Yan Y; Wang Z; Luo W
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):489-91. PubMed ID: 15291107
[TBL] [Abstract][Full Text] [Related]
20. [Heparanase expression of peripheral blood cells in steroid responsive nephrotic syndrome patients].
Yan Y; Wang Z; Tao YH
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):199-201. PubMed ID: 15144715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
